This $571,955.88 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for serological testing services and does not have a set-aside designation. Emory University has an extensive track record of performing federally funded research and providing services to government agencies through contracts and grants, including in areas such as infectious disease...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $144,702 firm-fixed-price purchase order to Emory University Office of Sponsored Programs for "LONG ARV" services. The order was placed on September 13, 2017, with a completion date of April 30, 2020. No set-aside designation was used. Emory University is a private university and non-profit organization that conducts public health research and programs for federal agencies, including...
The U.S. Centers for Disease Control and Prevention (CDC) awarded Emory University a $1,000,610.00 Delivery Order contract for the 2023 Clinical Immunization Safety Assessment (CISA) Base Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract, which has a period of performance through September 27, 2028, is for Emory to provide services related to the CISA program, which focuses on assessing the safety of vaccines and other immunizations. As a leading research institution, Emory...
Emory University Office of Sponsored Programs Division was awarded a $96,146 firm fixed price contract by the Centers for Disease Control and Prevention for support of the SARS COV-2 Broad Agency Announcement. No set-aside designation was applied. Work will be performed in Atlanta, Georgia through March 2022. This contract is likely associated with Emory University's previously awarded multiple award indefinite delivery contract from the CDC worth up to $86 million to provide clinical...
Emory University, operating as Emory University Office of Sponsored Programs Division, has been awarded a definitive contract by the Centers for Disease Control and Prevention (CDC) to perform work relating to determining antigenic drift with human monoclonal antibodies to hemagglutinin. Valued at approximately $901,182, this firm fixed price contract will be performed in Atlanta, Georgia over a two-year period concluding in September 2021. As part of its broader infectious disease programs, the...
This is a $10,168,423.08 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia, for the provision of clinic care services. The contract has an ultimate completion date of August 31, 2020 and is a cost-no-fee arrangement. Emory University is a major recipient of federal contracts and grants, with an extensive track record of conducting biomedical research, public health, and clinical studies...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract is for laboratory analysis services with a firm fixed price of $77,297.50 and a completion date of September 14, 2023. Emory University has an extensive track record of performing federally funded research and providing services to the government, including work for the CDC...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for $125,123.27 in firm fixed-price laboratory analysis services. It has a completion date of September 15, 2023. Emory University is the prime contractor on this contract, which is not set aside for any specific socioeconomic category. Emory is a major recipient of federal research contracts and grants,...
This is a $245,000.00 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, to Emory University, a private non-profit research institution. The contract, titled "FLUCRYOEM," does not have a set-aside designation and is expected to be completed by August 24, 2024. Emory University, through its Office of Sponsored Programs Division, is a major recipient of federal contracts and grants, often partnering with the...
Emory University is providing clinical immunization safety assessment support services to the National Institutes of Health National Institute of Allergy and Infectious Diseases under Delivery Order 15-0108 B1C1D1 0092A18. This $979,663.75 delivery order was awarded on April 2, 2018 against the Vaccine and Treatment Evaluation Units multiple award indefinite delivery contract. No set-aside designation was applied. Emory University will complete the work by September 30, 2021 in Atlanta, Georgia....